PMID: 16529031Mar 15, 2006Paper

Pharmacogenomics in chemotherapy and drug development for breast cancer

Nihon rinsho. Japanese journal of clinical medicine
Chikako Shimizu, Yasuhiro Fujiwara

Abstract

Tumor response and toxicities are different among individual patients. Pharmacogenomics studies aim to elucidate the genetic bases for interindividual differences and to allow individualization of care, using the knowledge of molecular biology, recently developed high-throughput biotechnology and bioinformatics. Transcription profiling of gene expression have been extensively studied in breast cancer. Breast cancer may be re-subclassified into subtypes according to molecular profiles with distinct differences in prognosis and response to therapy. Although there still lay problems in standardization of methodology and statistical validation, genomics studies have the potential to play the key role in the development of novel therapeutical strategies in the management of breast cancer.

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
James D BrentonCarlos Caldas
Rinsho byori. The Japanese journal of clinical pathology
H Miyachi
Surgical Oncology Clinics of North America
Joseph A SparanoParaic A Kenny
© 2021 Meta ULC. All rights reserved